Search Results - "Yun, M.R."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma by Kim, H.R., Kang, H.N., Shim, H.S., Kim, E.Y., Kim, J., Kim, D.J., Lee, J.G., Lee, C.Y., Hong, M.H., Kim, S.-M., Kim, H., Pyo, K.-H., Yun, M.R., Park, H.J., Han, J.Y., Youn, H.A., Ahn, M.-J., Paik, S., Kim, T.-M., Cho, B.C.

    Published in Annals of oncology (01-06-2017)
    “…We conducted co-clinical trials in patient-derived xenograft (PDX) models to identify predictive biomarkers for the multikinase inhibitor dovitinib in lung…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK by Lee, Y-h, Yun, M R, Kim, H M, Jeon, B H, Park, B-C, Lee, B-W, Kang, E S, Lee, H C, Park, Y W, Cha, B-S

    Published in International Journal of Obesity (01-02-2016)
    “…Background/Objectives: Activation of Notch signaling pathologically enhances lipogenesis and gluconeogenesis in the liver causing non-alcoholic fatty liver…”
    Get full text
    Journal Article
  5. 5
  6. 6